The status of US financial regulation, including the SEC’s climate-change disclosure rule, the Basel III endgame, cryptocurrencies and potential proposals on executive compensation were topics of discussion as Bloomberg Intelligence analysts Elliott Stein and Nathan Dean hosted Better Markets CEO and Co-Founder Dennis Kelleher. They also discussed how US regulation is changing in light of new court reviews and how regulators should approach promulgating new rules in the future.

The status of US financial regulation, including the SEC’s climate-change disclosure rule, the Basel III endgame, cryptocurrencies and potential proposals on executive compensation were topics of discussion as Bloomberg Intelligence analysts Elliott Stein and Nathan Dean hosted Better Markets CEO and Co-Founder Dennis Kelleher. They also discussed how US regulation is changing in light of new court reviews and how regulators should approach promulgating new rules in the future.

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.

Votes & Verdicts

Kelleher on FinReg, ‘Kangaroo’ Courts

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b35e0f29-1cb3-457c-83b3-b156010e44ff/transcript

US regulatory proposals on March 19 to lower capital requirements for JPMorgan, Bank of America and other banks lead this episode of Bloomberg Intelligence’s Votes and Verdicts podcast, with analysis from Nathan Dean. Matt Schettenhelm discusses Anthropic’s bid to halt the US designation of it as a supply-chain risk and FCC Chair Brendan Carr’s threats to revoke TV licenses for broadcasters, including Disney’s ABC. Holly Froum analyzes a 60-day waiver of the Jones Act and a Supreme Court case concerning liability of transportation brokers including CH Robinson. Justin Teresi explores President Donald Trump’s push to let Sable Offshore restart an offshore oil project in California and a Senate bill to break up the meatpacking industry. Elliott Stein discusses the DOJ’s probe of Federal Reserve Chair Jerome Powell and litigation between states and prediction markets.

US regulatory proposals on March 19 to lower capital requirements for JPMorgan, Bank of America and other banks lead this episode of Bloomberg Intelligence&rsquo;s Votes and Verdicts podcast, with analysis from Nathan Dean. Matt Schettenhelm discusses Anthropic&rsquo;s bid to halt the US designation of it as a supply-chain risk and FCC Chair Brendan Carr&rsquo;s threats to revoke TV licenses for broadcasters, including Disney&rsquo;s ABC. Holly Froum analyzes a 60-day waiver of the Jones Act and a Supreme Court case concerning liability of transportation brokers including CH Robinson. Justin Teresi explores President Donald Trump&rsquo;s push to let Sable Offshore restart an offshore oil project in California and a Senate bill to break up the meatpacking industry. Elliott Stein discusses the DOJ&rsquo;s probe of Federal Reserve Chair Jerome Powell and litigation between states and prediction markets.

Bank Rules, Anthropic, Sable, DOJ v. Powell

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e08a3d67-d6b9-44ac-a421-b4120175ea26/transcript

Antitrust law has come into sharper focus over the past year, with several high-profile cases, including in Big Tech. Bilal Sayyed, former Director of the FTC’s Office of Policy Planning and current competition counsel at TechFreedom, as well as counsel at the law firm Cadwalader, Wickersham and Taft, joins Bloomberg Intelligence litigation analysts Jennifer Rie and Justin Teresi on this Votes and Verdicts episode to talk about the state of US antitrust enforcement one year into the Trump administration. They discuss whether antitrust enforcement has become politicized (or more politicized), the departure of Gail Slater from the DOJ, the firing of the two Democratic FTC commissioners and various policy initiatives of the FTC’s Bureau of Competition and the DOJ’s Antitrust Division.

Antitrust law has come into sharper focus over the past year, with several high-profile cases, including in Big Tech. Bilal Sayyed, former Director of the FTC&rsquo;s Office of Policy Planning and current competition counsel at TechFreedom, as well as counsel at the law firm Cadwalader, Wickersham and Taft, joins Bloomberg Intelligence litigation analysts Jennifer Rie and Justin Teresi on this Votes and Verdicts episode to talk about the state of US antitrust enforcement one year into the Trump administration. They discuss whether antitrust enforcement has become politicized (or more politicized), the departure of Gail Slater from the DOJ, the firing of the two Democratic FTC commissioners and various policy initiatives of the FTC&rsquo;s Bureau of Competition and the DOJ&rsquo;s Antitrust Division.

Sayyed on the State of Antitrust Enforcement

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3a448477-604b-4200-b46c-b40c00e7be96/transcript

Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode, BI litigation analysts Holly Froum and Matthew Schettenhelm are joined by mass tort expert Joseph Fantini to discuss some of the major hurdles facing companies, including weedkiller cancer claims against Bayer’s Monsanto, NEC litigation against Abbott and Reckitt’s Mead Johnson unit, talc litigation against Johnson & Johnson, social-media addiction lawsuits against Meta, Google and others, and more. They discuss potential catalysts on the horizon, the strength of cases and the likelihood of any global settlements.

Companies facing multibillion-dollar exposure from mass tort personal-injury litigation have faced massive jury verdicts in 2026, and the trend shows no sign of slowing. In this Votes and Verdicts episode, BI litigation analysts Holly Froum and Matthew Schettenhelm are joined by mass tort expert Joseph Fantini to discuss some of the major hurdles facing companies, including weedkiller cancer claims against Bayer&rsquo;s Monsanto, NEC litigation against Abbott and Reckitt&rsquo;s Mead Johnson unit, talc litigation against Johnson &amp; Johnson, social-media addiction lawsuits against Meta, Google and others, and more. They discuss potential catalysts on the horizon, the strength of cases and the likelihood of any global settlements.

Bayer, Abbott, J&J Billion-Dollar Tort Risk

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9028af34-b56e-4c53-a028-b40500f79058/transcript

Kelleher on FinReg, ‘Kangaroo’ Courts

In 1 playlist(s)

Votes & Verdicts

Social links

Follow podcast

Recent clips